| A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends L Meddings, RP Myers, J Hubbard, AA Shaheen, KB Laupland, E Dixon, ... Official journal of the American College of Gastroenterology| ACG 105 (1 …, 2010 | 398 | 2010 |
| The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection EJ Gane, YS Lim, SC Gordon, K Visvanathan, E Sicard, RN Fedorak, ... Journal of hepatology 63 (2), 320-328, 2015 | 243 | 2015 |
| Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma S D'souza, KCK Lau, CS Coffin, TR Patel World journal of gastroenterology 26 (38), 5759, 2020 | 221 | 2020 |
| Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy KW Burak, MG Swain, T Santodomino-Garzon, SS Lee, SJ Urbanski, ... Canadian Journal of Gastroenterology and Hepatology 27 (5), 273-280, 2013 | 204 | 2013 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The lancet Gastroenterology & hepatology 8 (10), 879-907, 2023 | 191 | 2023 |
| Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract GR Martin, GW McKnight, MS Dicay, CS Coffin, JGP Ferraz, JL Wallace Digestive and Liver Disease 42 (2), 103-109, 2010 | 165 | 2010 |
| Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis TI Michalak, IU Pardoe, CS Coffin, ND Churchill, DS Freake, P Smith, ... Hepatology 29 (3), 928-938, 1999 | 163 | 1999 |
| Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023 EE Conners MMWR. Recommendations and Reports 72, 2023 | 156 | 2023 |
| Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease JXQ Pang, S Zimmer, S Niu, P Crotty, J Tracey, F Pradhan, AAM Shaheen, ... PloS one 9 (4), e95776, 2014 | 150 | 2014 |
| chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease MJ Shale, CH Seow, CS Coffin, GG Kaplan, R Panaccione, S Ghosh Alimentary pharmacology & therapeutics 31 (1), 20-34, 2010 | 150 | 2010 |
| New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection CS Coffin, K Zhou, NA Terrault Gastroenterology 156 (2), 355-368. e3, 2019 | 141 | 2019 |
| Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B) HLY Chan, SH Ahn, TT Chang, CY Peng, D Wong, CS Coffin, SG Lim, ... Journal of hepatology 64 (5), 1011-1019, 2016 | 130 | 2016 |
| Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver TI Michalak, PM Mulrooney, CS Coffin Journal of virology 78 (4), 1730-1738, 2004 | 129 | 2004 |
| Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis CS Coffin, TI Michalak The Journal of clinical investigation 104 (2), 203-212, 1999 | 129 | 1999 |
| Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy CS Coffin, PM Mulrooney‐Cousins, G van Marle, JP Roberts, TI Michalak, ... Liver Transplantation 17 (8), 955-962, 2011 | 119 | 2011 |
| Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines CS Coffin, SK Fung, MM Ma Canadian Journal of Gastroenterology and Hepatology 26 (12), 917-938, 2012 | 111 | 2012 |
| HBV and HIV Coinfection and Liver Transplant CS Coffin, PG Stock, LM Dove, CL Berg, NN Nissen, MP Curry, M Ragni, ... American Journal of Transplantation 10 (5), 1268-1275, 2010 | 110 | 2010 |
| Pregnancy outcomes among liver transplant recipients in the United States: a nationwide case‐control analysis CS Coffin, AAM Shaheen, KW Burak, RP Myers Liver transplantation 16 (1), 56-63, 2010 | 110 | 2010 |
| Occult hepatitis C virus infection: what does it mean? TNQ Pham, CS Coffin, TI Michalak Liver International 30 (4), 502-511, 2010 | 94 | 2010 |
| Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial F Zoulim, C Fournier, F Habersetzer, M Sprinzl, S Pol, CS Coffin, V Leroy, ... Human Vaccines & Immunotherapeutics 16 (2), 388-399, 2020 | 91 | 2020 |
Kelly BurakProfessor, University of CalgaryPotvrđena adresa e-pošte na ucalgary.ca